The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors.
Carucci M, Clamp A, Zhou C, Hurt C, Glasspool R, Monaghan PJ, Thirkettle S, Wheatley M, Mahmood M, Narasimham M, Cox T, Morrison H, Campbell S, Nelson A, Holland-Hart D, Hopewell-Kelly N, Thomas A, Porter C, Slusarczyk M, Irving A, Dive C, Adams R, Jayson GC.
Carucci M, et al. Among authors: wheatley m.
BMC Cancer. 2024 Oct 24;24(1):1309. doi: 10.1186/s12885-024-13073-0.
BMC Cancer. 2024.
PMID: 39448911
Free PMC article.